glp-1 agonists drugs Market Overview: and the Obesity Market | Blog GLP-1 Receptor Agonists and Research
Description
Long acting amylin receptor agonist, AZD6234, shows advantages over GLP-1 receptor agonist activation for leptin re-sensitization in a diet-induced obese (DIO) rat model
However, new research presented in 2024 highlights a troubling link between certain GLP-1 drugs, such as Ozempic and Wegovy, and a condition known as drug-induced gastroparesis
This does not mean stopping treatment
Trinh TA, Le TMD, Nguyen HTT, Nguyen TL, Kim J, Huynh DP, et al
